Gynaecological vulval definitive or neoadjuvant EBRT with or without chemotherapy (eviQ ID 3749)

Endorsed eviQ protocol for definitive or neoadjuvant external beam radiotherapy for vulvar cancer, with or without weekly cisplatin. It covers supine frog-leg setup, wiring of scars and clinical mark-up, bolus for superficial disease, MRI and PET/CT for delineation, SIB or sequential-boost dose levels, CTV rules for the vulva, nodes and the subcutaneous mons bridge (referencing the Gaffney 2016 consensus), and the same organ table as its cervix and endometrium protocols. A companion protocol (eviQ 3748) covers post-operative treatment. Its review is due 31 December 2026.

A definitive vulvar protocol with frog-leg setup, bolus guidance, SIB and sequential dose levels, detailed CTV rules by extent of disease and an organ table.